Why the study?
The study aimed to describe the 1-year outcomes of patients undergoing ablative procedures for AF in a cardiosurgical setting.
What are the 1-year clinical and rhythm outcomes of patients undergoing surgical ablation for atrial fibrillation?
What are the 1-year clinical and rhythm outcomes of patients undergoing surgical ablation for atrial fibrillation?
Surgical ablation for atrial fibrillation, whether stand-alone or concomitant, is associated with significant symptom improvement and over 60% sinus rhythm maintenance at 1 year.
No clinical study data available; leaves open questions on 1-year outcomes after surgical ablation for AF.
Objectives This study of German Cardiosurgery Atrial Fibrillation (CASE-AF) registry aims to describe the 1-year outcomes of patients undergoing ablative procedures for atrial fibrillation (AF) in a cardiosurgical setting. Methods Between January 2017 and April 2020, 17 German cardiosurgical units enrolled 1,000 consecutive patients undergoing concomitant or stand-alone ablation for AF. In-hospital and 1-year follow-up data were collected on web-based electronic case report forms. The protocol mandated telephone-based follow-up contact after 1 year. Results At 1-year follow-up (median, 14.5 months [12.6–18.2 months]), significant improvement (p < 0.0001) in baseline modified European Heart Rhythm Association Class I was reported in both concomitant and stand-alone patients. Follow-up examinations were completed in 97.9% of cases, and a sinus rhythm was reported in 60.2 and 63.6% of stand-alone and concomitant patients, respectively. Statistically significant factors determining late recurrence were female gender (p = 0.013), preoperative persistent AF (p < 0.0001), and presence of cardiac implantable electronic device (p = 0.011). All-cause mortality at 1 year was 1% (n = 1) in stand-alone patients and 6.7% (n = 58) in concomitant patients. Conclusion Surgical ablation of AF is safe and provides satisfactory results at short-term follow-up, with significant improvement in patient symptoms. Adequate cardiac rhythm monitoring should be prioritized for higher quality data acquisition.
No takes yet. Share an insight, caveat, or question.
Wehbe et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: